Literature DB >> 29238109

Present and future roles of FDG-PET/CT imaging in the management of gastrointestinal cancer: an update.

Kazuhiro Kitajima1, Masatoyo Nakajo2, Hayato Kaida3, Ryogo Minamimoto4, Kenji Hirata5, Masakatsu Tsurusaki3, Hiroshi Doi6, Yoshiko Ueno7, Keitaro Sofue7, Yukihisa Tamaki8, Koichiro Yamakado9.   

Abstract

Positron emission tomography/computed tomography (PET/CT) integrated with 2-[18F]fluoro-2-deoxy-D-glucose (FDG) is a useful tool for acquisition of both glucose metabolism and anatomic imaging data, as only a single device and one diagnostic session is required, thus opening a new field in clinical oncologic imaging. FDG-PET/CT has been successfully used for initial staging, restaging, assessment of early treatment response, evaluation of metastatic disease response, and prognostication of intestinal cancer as well as various malignant tumors. We reviewed the current status and role of FDG-PET/CT for management of patients with esophageal cancer, gastric cancer, and colorectal cancer, with focus on both its usefulness and limitations.

Entities:  

Keywords:  colorectal cancer; esophageal cancer; fluorodeoxyglucose (FDG); gastric cancer; positron emission tomography/computed tomography (PET/CT)

Mesh：

Substances：

Year:  2017        PMID： 29238109      PMCID： PMC5719212          DOI： 10.18999/nagjms.79.4.527

Source DB:  PubMed          Journal:  Nagoya J Med Sci        ISSN： 0027-7622            Impact factor:   1.131


  54 in total

1.  Positron emission tomography/computed tomography in the staging of colon cancer.

Authors:  Jae Hyung Lee; Min Ro Lee
Journal:  Ann Coloproctol       Date:  2014-02-28

2.  Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials.

Authors:  Vera Oppedijk; Ate van der Gaast; Jan J B van Lanschot; Pieter van Hagen; Rob van Os; Caroline M van Rij; Maurice J van der Sangen; Jannet C Beukema; Heidi Rütten; Patty H Spruit; Janny G Reinders; Dick J Richel; Mark I van Berge Henegouwen; Maarten C C M Hulshof
Journal:  J Clin Oncol       Date:  2014-01-13       Impact factor: 44.544

3.  Failure in presumption of residual disease by quantification of FDG uptake in esophageal squamous cell carcinoma immediately after radiotherapy.

Authors:  Ryuji Nakamura; Toya Obara; Shigehiko Katsuragawa; Yoshiharu Tamakawa; Keisuke Koeda; Kenichiroh Ikeda; Nobuhiro Sato; Kaoru Ishida; Masanori Shozushima
Journal:  Radiat Med       Date:  2002 Jul-Aug

Review 4.  PET/Computed Tomography in the Diagnosis and Staging of Gastric Cancers.

Authors:  Nouf Malibari; Marc Hickeson; Robert Lisbona
Journal:  PET Clin       Date:  2015-04-08

5.  The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma.

Authors:  Hiroyuki Kato; Tatsuya Miyazaki; Masanobu Nakajima; Junko Takita; Hitoshi Kimura; Ahmad Faried; Makoto Sohda; Yasuyuki Fukai; Norihiro Masuda; Minoru Fukuchi; Ryokuhei Manda; Hitoshi Ojima; Katsuhiko Tsukada; Hiroyuki Kuwano; Noboru Oriuchi; Keigo Endo
Journal:  Cancer       Date:  2005-01-01       Impact factor: 6.860

Review 6.  Role of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography in gastrointestinal cancers.

Authors:  Mathieu Gauthé; Marion Richard-Molard; Wulfran Cacheux; Pierre Michel; Jean-Louis Jouve; Emmanuel Mitry; Jean-Louis Alberini; Astrid Lièvre
Journal:  Dig Liver Dis       Date:  2015-02-19       Impact factor: 4.088

Review 7.  Prognostic significance of SUV on PET/CT in patients with esophageal cancer: a systematic review and meta-analysis.

Authors:  LingLing Pan; Ping Gu; Gang Huang; HuiPing Xue; ShuQi Wu
Journal:  Eur J Gastroenterol Hepatol       Date:  2009-09       Impact factor: 2.566

8.  Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma.

Authors:  Seung Hyup Hyun; Joon Young Choi; Young Mog Shim; Kwhanmien Kim; Su Jin Lee; Young Seok Cho; Ji Young Lee; Kyung-Han Lee; Byung-Tae Kim
Journal:  Ann Surg Oncol       Date:  2009-10-14       Impact factor: 5.344

Review 9.  Diagnostic Performance of ¹⁸F-FDG PET and PET/CT for the Detection of Recurrent Esophageal Cancer After Treatment with Curative Intent: A Systematic Review and Meta-Analysis.

Authors:  Lucas Goense; Peter S N van Rossum; Johannes B Reitsma; Marnix G E H Lam; Gert J Meijer; Marco van Vulpen; Jelle P Ruurda; Richard van Hillegersberg
Journal:  J Nucl Med       Date:  2015-05-07       Impact factor: 10.057

10.  What is the most accurate whole-body imaging modality for assessment of local and distant recurrent disease in colorectal cancer? A meta-analysis : imaging for recurrent colorectal cancer.

Authors:  Monique Maas; Iris J G Rutten; Patty J Nelemans; Doenja M J Lambregts; Vincent C Cappendijk; Geerard L Beets; Regina G H Beets-Tan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-04-06       Impact factor: 9.236
View more
  18 in total

Review 1.  [Importance of FDG-PET/computed tomography in colorectal cancer].

Authors:  S Kleiner; W Weber
Journal:  Radiologe       Date:  2019-09       Impact factor: 0.635

2.  Multiple metabolic parameters and visual assessment of 18F-FDG uptake heterogeneity of PET/CT in advanced gastric cancer and primary gastric lymphoma.

Authors:  Yixuan Ren; Juan Liu; Ling Wang; Yongjun Luo; Xiaofang Ding; Aiqi Shi; Jiangyan Liu
Journal:  Abdom Radiol (NY)       Date:  2020-11

3.  Usefulness of [68Ga]Ga-DOTA-FAPI-04 PET/CT in patients presenting with inconclusive [18F]FDG PET/CT findings.

Authors:  Haojun Chen; Liang Zhao; Dan Ruan; Yizhen Pang; Bing Hao; Yaqing Dai; Xiurong Wu; Wei Guo; Chunlei Fan; Jingxun Wu; Weipeng Huang; Qin Lin; Long Sun; Hua Wu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-06-25       Impact factor: 9.236

Review 4.  Cancer metabolism and tumor microenvironment: fostering each other?

Authors:  Yiyuan Yuan; Huimin Li; Wang Pu; Leilei Chen; Dong Guo; Hongfei Jiang; Bo He; Siyuan Qin; Kui Wang; Na Li; Jingwei Feng; Jing Wen; Shipeng Cheng; Yaguang Zhang; Weiwei Yang; Dan Ye; Zhimin Lu; Canhua Huang; Jun Mei; Hua-Feng Zhang; Ping Gao; Peng Jiang; Shicheng Su; Bing Sun; Shi-Min Zhao
Journal:  Sci China Life Sci       Date:  2021-11-26       Impact factor: 6.038

5.  It's Not What You Take Up, It's What You Keep: How Discoveries from Diverse Disciplines Directed the Development of the FDG PET/CT Scan.

Authors:  Jonathan D Kaunitz; Mark Mandelkern; Joanna S Fowler
Journal:  Dig Dis Sci       Date:  2022-07-30       Impact factor: 3.487

6.  Utility of PET Scans in the Diagnosis and Management of Gastrointestinal Tumors.

Authors:  Nandakumar Menon; Mark Mandelkern
Journal:  Dig Dis Sci       Date:  2022-07-30       Impact factor: 3.487

7.  Intelligent Reconstruction Algorithm-Based Computed Tomography Images for Automatic Detection of Gastric Tumor.

Authors:  Yuanyuan Zhang; Lisha Chen; Huixin Chen
Journal:  Comput Math Methods Med       Date:  2022-06-28       Impact factor: 2.809

8.  State-of-the-art of FAPI-PET imaging: a systematic review and meta-analysis.

Authors:  Martina Sollini; Margarita Kirienko; Fabrizia Gelardi; Francesco Fiz; Noemi Gozzi; Arturo Chiti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-06-25       Impact factor: 9.236

9.  Added value of MRI to endoscopic and endosonographic response assessment after neoadjuvant chemoradiotherapy in oesophageal cancer.

Authors:  Sophie E Vollenbrock; Jolanda M van Dieren; Francine E M Voncken; Sietze T van Turenhout; Liudmila L Kodach; Koen J Hartemink; Johanna W van Sandick; Berthe M P Aleman; Regina G H Beets-Tan; Annemarieke Bartels-Rutten
Journal:  Eur Radiol       Date:  2020-01-21       Impact factor: 5.315

10.  68Ga-DOTA-FAPI-04 PET/MR in the Evaluation of Gastric Carcinomas: Comparison with 18F-FDG PET/CT.

Authors:  Chunxia Qin; Fuqiang Shao; Yongkang Gai; Qingyao Liu; Weiwei Ruan; Fang Liu; Fan Hu; Xiaoli Lan
Journal:  J Nucl Med       Date:  2021-04-16       Impact factor: 11.082
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.